Drugs / FOLFOX chemotherapy regimens
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05797467 Background | Apr 2023 → Apr 2030 expected | chemotherapy-induced toxicity, colorectal cancer | Sixth Affiliated Hospital, Sun Yat-sen University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FOLFOX chemotherapy regimens | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05797467 ↗ |